Patents by Inventor Thomas Subkowski

Thomas Subkowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes
    Patent number: 6555124
    Abstract: (Meth)acrylic acid copolymers are used to increase mucosal permeability, comonomers present being (meth)acrylic esters and/or other monomers capable of free-radical polymerization, and the (meth)acrylic acid:comonomer molar ratio varying from 99:1 to 1:99.
    Type: Grant
    Filed: February 1, 1999
    Date of Patent: April 29, 2003
    Assignee: BASF Aktiengesellschaft
    Inventors: Karl Kolter, Thomas Subkowski, Martin Raditsch, Volker Schehlmann
  • Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same
    Patent number: 6365155
    Abstract: Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof are used in pharmaceutical preparations and in diagnosis. Cells which express these antibodies, antibody fragments, mixtures or derivatives thereof are also disclosed.
    Type: Grant
    Filed: December 30, 1999
    Date of Patent: April 2, 2002
    Assignee: Abbott Laboratories
    Inventors: Thomas Subkowski, Wilfried Hornberger
  • Endothelin converting enzyme (ECE)
    Patent number: 6066502
    Abstract: The invention relates to endothelin-converting enzymes containing the polypeptide sequence described in SEQ. ID. NO. 30 or SEQ. ID. NO. 36 or functional fragments thereof, genes which code for such enzymes, and processes for producing the said enzymes and the use thereof.
    Type: Grant
    Filed: May 16, 1996
    Date of Patent: May 23, 2000
    Assignee: BASF Aktiengesellschaft
    Inventors: Burkhard Kroger, Harald Seulberger, Thomas Meyer, Martin Schmidt, Elard Jacob, Rainer Otter, Thomas Subkowski, Heinz Hillen
  • Method of identifying a lipase for treatment of digestive disorders
    Patent number: 6030798
    Abstract: The use of bacterial lipases which show an immunological cross-reaction with the antibodies to the lipase produced by the microorganism Pseudomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057 for producing drugs for the therapy of maldigestion is described.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: February 29, 2000
    Assignee: BASF Aktiengesellschaft
    Inventors: Reinhard Braatz, Roland Kurth, Elke Menkel-Conen, Hansjoerg Rettenmaier, Thomas Friedrich, Thomas Subkowski
  • Conjugates of hirudin and lipophilic compounds
    Patent number: 5919762
    Abstract: The invention relates to novel hirudin conjugates formed from a hirudin and one or more lipophilic compounds, where the lipophilic compound has an octanol/water partition coefficient of more than 1.8 and is chemically linked to the hirudin, to the preparation thereof and to the use thereof.
    Type: Grant
    Filed: May 31, 1996
    Date of Patent: July 6, 1999
    Assignee: BASF Aktiengesellschaft
    Inventors: Jurgen Schweden, Peter Eckes, Wilfried Hornberger, Thomas Subkowski
  • Use of lipases for producing drugs
    Patent number: 5645832
    Abstract: The use of bacterial lipases which show an immunological cross-reaction with the antibodies to the lipase produced by the microorganism Pseudomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057 for producing drugs for the therapy of maldigestion is described.
    Type: Grant
    Filed: April 17, 1995
    Date of Patent: July 8, 1997
    Assignee: BASF Aktiengesellschaft
    Inventors: Reinhard Braatz, Roland Kurth, Elke Menkel-Conen, Hansjoerg Rettenmaier, Thomas Friedrich, Thomas Subkowski
  • Lipase from Pseudomonas and strain
    Patent number: 5489530
    Abstract: The use of bacterial lipases which show an immunological cross-reaction with the antibodies to the lipase produced by the microorganism Pseudomonas spec. DSM 6483 and/or Pseudomonas cepacia IAM 1057 for producing drugs for the therapy of maldigestion is described.
    Type: Grant
    Filed: December 28, 1993
    Date of Patent: February 6, 1996
    Assignee: BASF Aktiengesellschaft
    Inventors: Reinhard Braatz, Roland Kurth, Elke Menkel-Conen, Hansjoerg Rettenmaier, Thomas Friedrich, Thomas Subkowski
  • Proteins and the preparation thereof
    Patent number: 5344915
    Abstract: Novel proteins which have a molecular weight of about 42,000 daltons and have at the N terminus the amino acid sequenceXaa Thr Pro Tyr Ala Pro Glu Pro Gly Set Thr Cys Arg Leu Arg Gluwhere X is hydrogen, a phenylalanine residue (Phe) or the amino acid sequences Ala Phe, Val Ala Phe, Gln Val Ala Phe, Ala Gln Val Ala Phe, Pro Ala Gln Val Ala Phe or Leu Pro Ala Gln Val Ala Phe, and which are suitable for the treatment of diseases, are described.
    Type: Grant
    Filed: September 26, 1991
    Date of Patent: September 6, 1994
    Assignee: BASF Aktiengesellschaft
    Inventors: Hans-Georg LeMaire, Heinz Hillen, Achim Moeller, Lothar Daum, Thomas Doerper, Thomas Subkowski